Successful treatment with belimumab of severe systemic lupus erythematosus not responding to standard therapy: a case report

Successful treatment with belimumab of severe systemic lupus erythematosus not responding to standard therapy: a case report

Systemic Lupus Erythematosus (SLE) is an autoimmune disease characterized by complex pathophysiology and heterogeneous clinical picture. Belimumab is the first biological therapy licensed for SLE. We report the case of a 24 years old woman affected by a severe form of systemic lupus erythematosus w...

Full description

Bibliographic Details
Main Authors: Ottavia Magnani, Elena Penza, Giuseppe Murdaca, Francesco Puppo
Format: Article
Language:English
Published: SEEd 2016-03-01
Series:Clinical Management Issues
Subjects:
Systemic Lupus Erythematosus (SLE)
Belimumab
Biological Therapy
Online Access:https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1227

Similar Items

Similar Items